Given a relatively low predictive value of serologic tests in patients with immune disorders, including HIV-infection with CD4+ count <100 cells/mm3 and molecular testing characterized by higher sensitivity and specificity, is proposed [16,36,40,46]. The gene discussed is CD4; the disease is immune system disorder.